全文获取类型
收费全文 | 1701篇 |
免费 | 124篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 100篇 |
儿科学 | 70篇 |
妇产科学 | 22篇 |
基础医学 | 282篇 |
口腔科学 | 7篇 |
临床医学 | 139篇 |
内科学 | 342篇 |
皮肤病学 | 17篇 |
神经病学 | 304篇 |
特种医学 | 147篇 |
外国民族医学 | 3篇 |
外科学 | 165篇 |
综合类 | 15篇 |
预防医学 | 62篇 |
眼科学 | 43篇 |
药学 | 98篇 |
中国医学 | 2篇 |
肿瘤学 | 47篇 |
出版年
2021年 | 16篇 |
2020年 | 11篇 |
2019年 | 32篇 |
2018年 | 33篇 |
2017年 | 27篇 |
2016年 | 33篇 |
2015年 | 35篇 |
2014年 | 61篇 |
2013年 | 52篇 |
2012年 | 79篇 |
2011年 | 69篇 |
2010年 | 48篇 |
2009年 | 42篇 |
2008年 | 59篇 |
2007年 | 76篇 |
2006年 | 48篇 |
2005年 | 55篇 |
2004年 | 59篇 |
2003年 | 55篇 |
2002年 | 38篇 |
2001年 | 49篇 |
2000年 | 45篇 |
1999年 | 40篇 |
1998年 | 31篇 |
1997年 | 30篇 |
1996年 | 29篇 |
1995年 | 30篇 |
1994年 | 20篇 |
1993年 | 14篇 |
1992年 | 46篇 |
1991年 | 30篇 |
1990年 | 40篇 |
1989年 | 56篇 |
1988年 | 49篇 |
1987年 | 42篇 |
1986年 | 37篇 |
1985年 | 41篇 |
1984年 | 22篇 |
1983年 | 28篇 |
1982年 | 22篇 |
1981年 | 20篇 |
1980年 | 16篇 |
1979年 | 31篇 |
1978年 | 30篇 |
1977年 | 32篇 |
1976年 | 17篇 |
1975年 | 21篇 |
1974年 | 11篇 |
1971年 | 8篇 |
1970年 | 7篇 |
排序方式: 共有1865条查询结果,搜索用时 15 毫秒
931.
Marina Brigui Sorin Aldea Michele Bernier Saad Bennis Etienne Mireau Stephan Gaillard 《Journal of clinical neuroscience》2013,20(2):317-319
We report two patients with thoracic spinal solitary fibrous tumor (SFT). This report includes a patient with the first secondary SFT arising in the central nervous system from a pleural origin to our knowledge. The diagnosis was confirmed by histological and immunohistochemical analysis. Both patients underwent gross total resection of their tumors and did not show signs of local recurrence. The patient with the secondary lesion later presented with visceral dissemination. We review the reports of spinal SFT and discuss the diagnosis and therapeutic management of this intriguing entity. 相似文献
932.
933.
934.
L. Bezrodnik M. S. Caldirola A. G. Seminario I. Moreira M. I. Gaillard 《Clinical and experimental immunology》2014,175(2):227-234
Regulatory T cells [Tregs; CD4+CD25+ forkhead box protein 3 (FoxP3+)] are subsets of T cells involved in the maintenance of peripheral self‐tolerance by actively suppressing the activation and expansion of autoreactive T cells. Signalling through the interleukin‐2 receptor (IL‐2R) contributes to T cell tolerance by controlling three important aspects of regulatory T cell (Treg) biology. CD25 is the α‐chain of the IL‐2R that, in concert with the β‐chain and γ‐chain, constitutes the complete IL‐2R. CD25 contributes only to IL‐2 binding affinity but not to the recruitment of signalling molecules. However, its importance in the development of a normal immune response is emphasized by the finding that a truncation mutant of CD25 results in an immunodeficiency in humans characterized by an increased susceptibility to viral, bacterial and fungal infections. In 1997, Sharfe et al. described an infant with severe bacterial, viral and fungal infections. Counts of autologous T lymphocytes were moderately low, T cells displayed a weak proliferative response to mitogens in vitro and the patient displayed no rejection of an allogeneic skin graft. However, unlike children with severe combined immunodeficiency (SCID), besides not having circulating T cells, the patient also developed peripheral lymphocytic proliferation and autoimmune primary biliary cirrhosis. We present the first female Argentine patient with mutation in CD25 associated with chronic and severe inflammatory lung disease (follicular bronchiolitis with lymphocyte hyperplasia), eczema and infections. She has no expression of CD25 on CD4+ T cells and an extremely low amount of Tregs. The molecular study confirmed homozygous missense mutation in the alpha subunit of the IL‐2 receptor (CD25αR) (c. 122 a > c; p. Y41S). 相似文献
935.
M. F. Engel A. H. W. Bruns M. E. J. L. Hulscher C. A. J. M. Gaillard S. U. C. Sankatsing F. Teding van Berkhout M. H. Emmelot-Vonk E. M. Kuck M. H. M. Steeghs J. H. den Breeijen R. K. Stellato A. I. M. Hoepelman J. J. Oosterheert 《European journal of clinical microbiology & infectious diseases》2014,33(11):1897-1908
We previously showed that 40 % of clinically stable patients hospitalised for community-acquired pneumonia (CAP) are not switched to oral therapy in a timely fashion because of physicians’ barriers. We aimed to decrease this proportion by implementing a novel protocol. In a multi-centre controlled before-and-after study, we evaluated the effect of an implementation strategy tailored to previously identified barriers to an early switch. In three Dutch hospitals, a protocol dictating a timely switch strategy was implemented using educational sessions, pocket reminders and active involvement of nursing staff. Primary outcomes were the proportion of patients switched timely and the duration of intravenous antibiotic therapy. Length of hospital stay (LOS), patient outcome, education effects 6 months after implementation and implementation costs were secondary outcomes. Statistical analysis was performed using mixed-effects models. Prior to implementation, 146 patients were included and, after implementation, 213 patients were included. The case mix was comparable. The implementation did not change the proportion of patients switched on time (66 %). The median duration of intravenous antibiotic administration decreased from 4 days [interquartile range (IQR) 2–5] to 3 days (IQR 2–4), a decrease of 21 % [95 % confidence interval (CI) 11 %; 30 %) in the multi-variable analysis. LOS and patient outcome were comparable before and after implementation. Forty-three percent (56/129) of physicians attended the educational sessions. After 6 months, 24 % (10/42) of the interviewed attendees remembered the protocol’s main message. Cumulative implementation costs were €5,798 (€20/reduced intravenous treatment day). An implementation strategy tailored to previously identified barriers reduced the duration of intravenous antibiotic administration in hospitalised CAP patients by 1 day, at minimal cost. 相似文献
936.
937.
938.
Julien Lazarovici Peggy Dartigues Pauline Brice Lucie Obéric Isabelle Gaillard Mathilde Hunault-Berger Florence Broussais-Guillaumot Emmanuel Gyan Serge Bologna Emmanuelle Nicolas-Virelizier Mohamed Touati Olivier Casasnovas Richard Delarue Frédérique Orsini-Piocelle Aspasia Stamatoullas Jean Gabarre Luc-Matthieu Fornecker Thomas Gastinne Fréderic Peyrade Virginie Roland Emmanuel Bachy Marc André Nicolas Mounier Christophe Fermé 《Haematologica》2015,100(12):1579-1586
Nodular lymphocyte predominant Hodgkin lymphoma represents a distinct entity from classical Hodgkin lymphoma. We conducted a retrospective study to investigate the management of patients with nodular lymphocyte predominant Hodgkin lymphoma. Clinical characteristics, treatment and outcome of adult patients with nodular lymphocyte predominant Hodgkin lymphoma were collected in Lymphoma Study Association centers. Progression-free survival (PFS) and overall survival (OS) were analyzed, and the competing risks formulation of a Cox regression model was used to control the effect of risk factors on relapse or death as competing events. Among 314 evaluable patients, 82.5% had early stage nodular lymphocyte predominant Hodgkin lymphoma. Initial management consisted in watchful waiting (36.3%), radiotherapy (20.1%), rituximab (8.9%), chemotherapy or immuno-chemotherapy (21.7%), combined modality treatment (12.7%), or radiotherapy plus rituximab (0.3%). With a median follow-up of 55.8 months, the 10-year PFS and OS estimates were 44.2% and 94.9%, respectively. The 4-year PFS estimates were 79.6% after radiotherapy, 77.0% after rituximab alone, 78.8% after chemotherapy or immuno-chemotherapy, and 93.9% after combined modality treatment. For the whole population, early treatment with chemotherapy or radiotherapy, but not rituximab alone (Hazard ratio 0.695 [0.320–1.512], P=0.3593) significantly reduced the risk of progression compared to watchful waiting (HR 0.388 [0.234–0.643], P=0.0002). Early treatment appears more beneficial compared to watchful waiting in terms of progression-free survival, but has no impact on overall survival. Radiotherapy in selected early stage nodular lymphocyte predominant Hodgkin lymphoma, and combined modality treatment, chemotherapy or immuno-chemotherapy for other patients, are the main options to treat adult patients with a curative intent. 相似文献
939.
940.
We previously documented that several erythroleukemia cell lines released factors that stimulated erythropoiesis in vivo and in vitro. A simple five-step scheme has been devised that allows purification of this erythropoietic activity to apparent homogeneity. The methods employed included lectin affinity chromatography (wheat germ agglutinin), gel filtration (ultro gel ACA44), ion exchange, hydroxylapatite, and high performance liquid chromatography. Following polyacrylamide gel electrophoresis, biologic activity was recovered in an area corresponding to a molecular weight of 35,000 daltons. Silver staining of a polyacrylamide gel after electrophoresis of our most purified preparation revealed a single band at 35,000 daltons. 相似文献